Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808196 · ClinicalTrials.gov registry record · Phase 2
Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
A Phase 2 study of Eosinophilic Esophagitis and Connective Tissue Disorders, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT01808196 is a Phase 2 study of Eosinophilic Esophagitis and Connective Tissue Disorders that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 6 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01808196, a Phase 2 study of Eosinophilic Esophagitis and Connective Tissue Disorders, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the safety of losartan potassium and see what effects (good and bad) it has on you and your eosinophilic esophagitis.
Conditions Studied
Interventions
- DRUG Losartan Potassium
Study Locations (1)
Ohio
- Kara Kliewer - Mason
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-10-10 |
| Est. Completion | 2015-02-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01808196
The ClinicalTrials.gov registry entry for NCT01808196 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which Losartan Potassium is the first listed.
NCT01808196 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01808196 about?
NCT01808196 is a clinical study titled "Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD". The purpose of this research study is to test the safety of losartan potassium and see what effects (good and bad) it has on you and your eosinophilic esophagitis.
What is the current status of trial NCT01808196?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2013-10-10. Estimated completion is 2015-02-13.
What conditions does trial NCT01808196 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis, Connective Tissue Disorders.
What interventions are being tested in trial NCT01808196?
The interventions under investigation include: Losartan Potassium (DRUG).
Who is sponsoring clinical trial NCT01808196?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01808196 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
RECRUITING · Phase 2
-
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
RECRUITING · Phase 2
-
Zemaira Eosinophilic Esophagitis Pilot Study
RECRUITING · Phase 2
-
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
COMPLETED · Phase 2
-
A Study of Flovent in Patients With Eosinophilic Esophagitis
COMPLETED · Phase 2
-
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.